ROLONJI Trademark

Trademark Overview

On Friday, April 24, 2020, a trademark application was filed for ROLONJI with the United States Patent and Trademark Office. The USPTO has given the ROLONJI trademark a serial number of 79286362. The federal status of this trademark filing is REGISTERED as of Tuesday, May 18, 2021. This trademark is owned by NOVARTIS AG. The ROLONJI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diabetes
rolonji

General Information

Serial Number79286362
Word MarkROLONJI
Filing DateFriday, April 24, 2020
Status700 - REGISTERED
Status DateTuesday, May 18, 2021
Registration Number6350654
Registration DateTuesday, May 18, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 2, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 5, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSandoz AG
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressCH
Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events

Event DateEvent Description
Friday, January 19, 2024CHANGE OF OWNER RECEIVED FROM IB
Monday, September 20, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, September 1, 2021FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, September 1, 2021FINAL DISPOSITION PROCESSED
Wednesday, August 18, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 18, 2021REGISTERED-PRINCIPAL REGISTER
Sunday, March 14, 2021NOTIFICATION PROCESSED BY IB
Tuesday, March 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 2, 2021PUBLISHED FOR OPPOSITION
Wednesday, February 24, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 24, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 28, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 6, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 5, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 5, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 8, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 8, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 8, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, September 8, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 8, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 8, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, September 5, 2020REFUSAL PROCESSED BY IB
Thursday, August 20, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, August 20, 2020REFUSAL PROCESSED BY MPU
Tuesday, July 14, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, July 13, 2020NON-FINAL ACTION WRITTEN
Sunday, July 5, 2020ASSIGNED TO EXAMINER
Tuesday, June 9, 2020APPLICATION FILING RECEIPT MAILED
Friday, June 5, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 4, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, May 28, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

rolonji diabetes treatment preparations pharmaceutical